Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Shares Outstanding (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Shares Outstanding for 6 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed 0.19% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, changed 0.19% year-over-year, with the annual reading at $1.9 million for FY2025, 0.19% changed from the prior year.
  • Shares Outstanding hit $1.9 million in Q4 2025 for Bolt Biotherapeutics, roughly flat from $1.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $38.0 million in Q3 2023 to a low of $1.9 million in Q4 2023.
  • Historically, Shares Outstanding has averaged $21.5 million across 5 years, with a median of $36.8 million in 2021.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 1817.71% in 2021 and later plummeted 94.96% in 2024.
  • Year by year, Shares Outstanding stood at $37.4 million in 2021, then grew by 1.06% to $37.8 million in 2022, then plummeted by 94.96% to $1.9 million in 2023, then rose by 0.59% to $1.9 million in 2024, then grew by 0.19% to $1.9 million in 2025.
  • Business Quant data shows Shares Outstanding for BOLT at $1.9 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.